Daiichi Sankyo (OTCMKTS:DSNKY) Stock Price Up 5.1% – Here’s What Happened

Shares of Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY) shot up 5.1% on Monday . The company traded as high as $23.32 and last traded at $22.50. 94,533 shares changed hands during mid-day trading, a decline of 63% from the average session volume of 255,678 shares. The stock had previously closed at $21.40.

Wall Street Analysts Forecast Growth

Separately, Zacks Research cut shares of Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research report on Wednesday, November 19th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy”.

Daiichi Sankyo Price Performance

The stock’s 50-day simple moving average is $24.19 and its two-hundred day simple moving average is $24.14. The firm has a market cap of $42.66 billion and a P/E ratio of 21.25. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.31 and a quick ratio of 1.60.

Daiichi Sankyo Company Profile

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.